Showing 1 - 8 results of 8 for search 'Hsin‐An Hou', query time: 0.02s
Refine Results
-
1
PHF6 and RUNX1 mutations cooperate to accelerate leukemogenesis by Yueh-Chwen Hsu, Chi-Yuan Yao, Chang-Tsu Yuan, Chien-Chin Lin, Hsin-An Hou, Chein-Jun Kao, Chia-Lang Hsu, Wen-Chien Chou, Hwei-Fang Tien
Published 2025-09-01Get full text
Article -
2
-
3
MERGE: A Multinational, Multicenter Observational Registry for Myeloproliferative Neoplasms in Asia, including Middle East, Turkey, and Algeria by Mohamed A. Yassin, Ali Taher, Vikram Mathews, Hsin‐An Hou, Tahir Shamsi, Tülin Firatli Tuğlular, Zhijian Xiao, Soo‐Jeong Kim, Wu Depei, Junmin Li, Gerd Rippin, Islam Sadek, Asif Siddiqui, Raymond S. Wong
Published 2020-07-01Get full text
Article -
4
Real-world treatment patterns and health care resource use for patients with myelofibrosis: results from the METER study by Vikas Gupta, Ciprian Tomuleasa, Gilberto Israel Barranco Lampón, Hsin-An Hou, Grzegorz Helbig, Pankit Vachhani, Argiris Symeonidis, Ibrahim Haznedaroglu, Kenny Galvez, Fernando Tatsch, Avijeet S. Chopra, Meng Zhang, Tamas Vizkelety, Bryan Murray, David M. Ross
Published 2025-03-01Get full text
Article -
5
A clinico-genomic prognostic model for primary myelodysplastic neoplasm in Asia by Harinder Gill, Rita Yim, Paul Lee, Xavier Cheng-Hong Tsai, Vivian W. K. Li, Garret M. K. Leung, Melissa Ooi, Tsz-Shing Hui, Radha Raghupathy, Lynn Chin, Lester Au, Qi Zhang, Tony K. Y. Wu, Carmen Y. Y. Lee, Wee-Joo Chng, Hwei-Fang Tien, Hsin-An Hou, Yok-Lam Kwong
Published 2025-07-01Get full text
Article -
6
Genomic and transcriptomic determinants of clinical outcomes in patients with AML and DNMT3A mutations by Sao-Chih Ni, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, Min-Yen Lo, Chien-Yuan Chen, Wan-Hsuan Lee, Chien-Chin Lin, Yuan-Yeh Kuo, Yen-Ling Peng, Mei-Hsuan Tseng, Yu-Sin Wu, Ming-Chih Liu, Liang-In Lin, Ming-Kai Chuang, Bor-Sheng Ko, Ming Yao, Jih-Luh Tang, Feng-Ming Tien, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Published 2025-05-01Get full text
Article -
7
Dose escalation study of the HLA-A2-WT1 CD3 bispecific antibody RO7283420 in relapsed/refractory acute myeloid leukemia by Martin Hutchings, Koorosh Korfi, Pau Montesinos, Armando Santoro, Hsin-An Hou, Pilar Martinez-Sanchez, Susana Vives, Sara Galimberti, Tsai-Yun Chen, Marco Frigeni, Sylvain Garciaz, Olga Salamero Garcia, Su-Peng Yeh, Karen Yee, Jordi Esteve, Ashish Bajel, Shaun Fleming, Anne Catherine Bretz, Jan Attig, Min Sun, Sina Nassiri, Tobias Rutishauser, Christian Klein, Y. May Ma, Gabriel Schnetzler, Stephanie Vauleon, Huixin Yu, Teresa Barata, Muriel Richard, Silke Simon, Heather Hinton, Nino Keshelava, Marion Subklewe
Published 2025-08-01Get full text
Article -
8
The impact of COPD–bronchiectasis association on clinical outcomes: insights from East Asian cohorts validating the ROSE criteria by Yen-Fu Chen, Chia-Ling Chang, Hsin-Han Hou, Ning Chien, Kai-Zen Lu, Ying-Yin Chen, Zheng-Ci Hung, Yi-Han Hsiao, Chau-Chyun Sheu, Ping-Huai Wang, Meng-heng Hsieh, Wu-Huei Hsu, Ming-Tsung Chen, Wei-Fan Ou, Yu-Feng Wei, Tsung-Ming Yang, Chou-Chin Lan, Cheng-Yi Wang, Chih-Bin Lin, Ming-Shian Lin, Yao-Tung Wang, Ching-Hsiung Lin, Shih-Feng Liu, Meng-Hsuan Cheng, Wen-Chien Cheng, Chung-Kan Peng, Ming-Cheng Chan, Ching-Yi Chen, Lun-Yu Jao, Ya-Hui Wang, Chi-Jui Chen, Shih-Pin Chen, Yi-Hsuan Tsai, Shih-Lung Cheng, Horng-Chyuan Lin, Jung-Yien Chien, Hao-Chien Wang, Chong-Jen Yu
Published 2025-03-01Get full text
Article